McAdam LLC’s Geron GERN Stock Holding History

McAdam LLC’s Portfolio GERN Stock Details GERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,000	Closed	-$3K	–	251
2018 Q3	$3K	Hold	2,000	–	–	﹤0.01%	472
2018 Q2	$7K	Hold	2,000	–	–	﹤0.01%	360
2018 Q1	$9K	Buy	+2,000	New	+$5.4K	﹤0.01%	337

Other funds holding GERN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

McAdam LLC's GERN Position: Q4 2018 in Review

McAdam LLC sold out of Geron (GERN) in Q4 2018, closing a stake of 2,000 shares — an estimated $3K sold.

McAdam LLC first reported a position in GERN in Q1 2018 and held it in 3 quarters. The position peaked at $9K in Q1 2018. 138 funds tracked by Wall St. Rank hold GERN as of Q4 2018.

McAdam LLC reported no remaining Geron position as of Q4 2018 after selling out during the quarter.
McAdam LLC sold 2,000 Geron shares in Q4 2018, an estimated $3K.
McAdam LLC first reported a position in Geron in Q1 2018 and held it in 3 quarters.
McAdam LLC's Geron position peaked at $9K in Q1 2018.
138 funds tracked by Wall St. Rank held Geron as of Q4 2018.

Based on McAdam LLC's 13F filing for Q4 2018, filed 30 Jan 2019.